C0807321||pathology report
C2347585||central pathology review
C0006142||breast cancer
C0677850||adjuvant treatment
C0683956||predictive factors
C0005516||markers
C0006142||breast cancer
C0677850||adjuvant therapy
C0206034||randomized clinical trials
C0807321||pathology report
C2347585||central pathology review
C0205276||local
C0205099||central
C0684224||histopathological report
C0035363||retrospective analysis
C1458155||breast cancer tumors
C0334866||local pathologists
C0587487||Pathology Division
C1708333||European Institute of Oncology
C0030664||central pathology
C0208804||Ki-67
C0441799||grading
C0019929||hormone receptors
C0034804||ER
C0034833||PgR
C1512413||HER2/neu
C0242481||Bland-Altman plots
C0208804||Ki-67
C0034804||ER
C0034833||PgR
C0034804||ER
C0034833||PgR
C0069515||HER2
C0444061||pathology specimens
C1513817||Cancer Centers
C0034804||ER
C0034833||PgR
C0208804||Ki-67
C0441799||grading
C0069515||HER2
C0069515||HER2
C0034804||ER
C0034833||PgR
C0069515||Her2
C0034804||ER
C0034833||PgR
C0033080||prescription
C0035363||retrospective analysis
C2347585||central pathological review
C0006142||breast cancer
C0008976||clinical trials